Literature DB >> 29652095

Decreases in neprilysin and vasoconstrictors and increases in vasodilators following bariatric surgery.

Husam Ghanim1, Scott Monte1, Joseph Caruana1, Kelly Green1, Sanaa Abuaysheh1, Paresh Dandona1.   

Abstract

The aim of this study was to determine if weight loss following Roux-en-Y gastric bypass (RYGB) surgery in morbidly obese patients is associated with a decrease in plasma concentrations of neprilysin, mediators of the renin angiotensin system (RAS), catecholamines and endothelin-1, and also with an increase in the concentrations of vasodilators. Fasting blood samples were obtained from 15 patients with morbid obesity and diabetes prior to and 6 months after RYGB surgery. Circulating levels of neprilysin, vasoconstrictors, vasodilators, and the mRNA expression of related genes in circulating mononuclear cells (MNC) were measured. Six months after RYGB surgery the concentrations of neprilysin, angiotensinogen, angiotensin II, renin and endothelin-1 fell significantly by 27 ±16%, 22 ±10%, 22 ±8%, 35 ±13% and 17 ±6% (P < .05 for all), respectively, while ANP concentrations increased significantly by 24 ±13%. There was no significant change in aldosterone, BNP, cAMP or cGMP concentrations, or angiotensin converting enzyme (ACE) expression. These changes may contribute to the reduction of congestive cardiac failure and blood pressure risks after RYGB surgery.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  obesity; vasoconstriction; vasodilation

Mesh:

Substances:

Year:  2018        PMID: 29652095     DOI: 10.1111/dom.13320

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  9 in total

Review 1.  Microvascular Endothelial Dysfunction in Patients with Obesity.

Authors:  Agostino Virdis; Stefano Masi; Rocchina Colucci; Martina Chiriacò; Monica Uliana; Ilaria Puxeddu; Nunzia Bernardini; Corrado Blandizzi; Stefano Taddei
Journal:  Curr Hypertens Rep       Date:  2019-04-04       Impact factor: 5.369

2.  Elevated plasma endothelin-1 is associated with reduced weight loss post vertical sleeve gastrectomy.

Authors:  Haley N Jenkins; London J Williams; Adam Dungey; Kenneth D Vick; Bernadette E Grayson; Joshua S Speed
Journal:  Surg Obes Relat Dis       Date:  2019-04-09       Impact factor: 4.734

Review 3.  Lifestyle interventions for the prevention and treatment of hypertension.

Authors:  Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia
Journal:  Nat Rev Cardiol       Date:  2020-10-09       Impact factor: 32.419

4.  PLASMA NEPRILYSIN LEVELS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME.

Authors:  O Oz Gul; P Sisman; S Cander; E Sarandol; C Ersoy; E Erturk
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

Review 5.  The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis.

Authors:  Laicheng Wang; Meihua Lin; Jianjian Yu; Zongcheng Fan; Shunpeng Zhang; Yunchai Lin; Xin Chen; Feng Peng
Journal:  Obes Surg       Date:  2021-09-14       Impact factor: 3.479

6.  Predictors and correlates of systolic blood pressure reduction with liraglutide treatment in patients with type 2 diabetes.

Authors:  Magnus O Wijkman; Mary Dena; Sofia Dahlqvist; Sheyda Sofizadeh; Irl Hirsch; Jaakko Tuomilehto; Johan Mårtensson; Ole Torffvit; Henrik Imberg; Aso Saeed; Marcus Lind
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-05       Impact factor: 3.738

7.  Liraglutide and systolic blood pressure.

Authors:  Paresh Dandona; Husam Ghanim; Ajay Chaudhuri
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-12-05       Impact factor: 3.738

Review 8.  Cardiovascular Effects of Metabolic Surgery on Type 2 Diabetes.

Authors:  Christos Damaskos; Alexandros Litos; Dimitrios Dimitroulis; Efstathios A Antoniou; Dimitrios Mantas; Konstantinos Kontzoglou; Nikolaos Garmpis
Journal:  Curr Cardiol Rev       Date:  2020

Review 9.  Heart failure with preserved ejection fraction based on aging and comorbidities.

Authors:  Ying Lin; Shihui Fu; Yao Yao; Yulong Li; Yali Zhao; Leiming Luo
Journal:  J Transl Med       Date:  2021-07-06       Impact factor: 5.531

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.